Absorption, Metabolism, and Excretion of CYC065 in Healthy Male Subjects
NCT05817890
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Fadraciclib
Sponsor
Cyclacel Pharmaceuticals, Inc.